You are here

Article info

Article menu
Download PDFPDF
PostScript
PostScript
Benefit of stopping finite nucleos(t)ide analogues therapy in chronic hepatitis B patients

Authors

  • Yun-Fan Liaw Liver Research Unit, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Wen-Juei Jeng Liver Research Unit, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taipei, Taiwan Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital, Linkou Medical Cente, Taipei, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Yun-Fan Liaw, Liver Research Unit, Chang Gung Memorial Hospital, 199, Tung Hwa North Road, Taipei 105, Taiwan; liveryfl{at}gmail.com
View Full Text

Citation

Liaw Y, Jeng W
Benefit of stopping finite nucleos(t)ide analogues therapy in chronic hepatitis B patients
Gut 2020;69:1898-1899.

Publication history

  • Received November 22, 2019
  • Revised November 26, 2019
  • Accepted November 26, 2019
  • First published November 29, 2019.
Online issue publication 
December 06, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.